Image: The QMENTA platform is designed to help investigators and doctors worldwide to aggregate and analyze thousands of imaging records all in one place (Photo courtesy of QMENTA).
QMENTA (Boston, MA, USA), a medical image storage, processing and visualization company focused on brain data analysis, specifically using MRI and related clinical data, has developed a cloud-based system for neuroimages and all related data, with data management, analysis and visualization capabilities.
QMENTA provides state-of-the-art medical image processing algorithms in a seamless way in order to accelerate the development of new therapies for neurological diseases via a scalable and collaborative cloud platform. The company’s purpose is to organize and quantify brain-imaging information, through complex imaging tools in a seamless manner. It aims to change the way patients are diagnosed and monitored, and disease progression and drug efficacy are measured.
The QMENTA platform has been created to help investigators and doctors worldwide to aggregate and analyze thousands of imaging records all in one place. The company’s clients upload their data (DICOM, NIfTI, etc.) to the QMENTA platform via easy drag & drop. The cloud platform facilitates efficient data and project management by allowing investigators and doctors to combine data from various sources and sites in the same place with easy query and search functionality. Both data and results can be easily shared between specialists through the cloud for enhanced collaboration.
All the data on the platform can be analyzed with one-click using state-of-the art pipelines on the cloud, eliminating hassles dealing with scripts, version control, reproducibility and many other complications, saving valuable time and resources. These customizable and flexible pipelines enable investigators to extract valuable, quantitative information from medical images. All data can be visualized in 2D or 3D (and touchless) using an integrated desktop visualization app.
QMENTA’s analytics support the discovery of new biomarkers for diagnostics by allowing investigators to easily explore correlations between changes in neuroanatomy and neurophysiology. This facilitates early and accurate diagnosis for neurological diseases and improves patient selection for clinical trials. The company aims to provide the cloud-based platform for experts, hospitals, research centers, and pharmaceutical companies to help optimize and accelerate their neuroimaging workflows.